Document Detail

Percutaneous left atrial appendage occlusion for stroke prevention in atrial fibrillation: an update.
MedLine Citation:
PMID:  25332785     Owner:  NLM     Status:  PubMed-not-MEDLINE    
Atrial fibrillation (AF) is the most common sustained cardiac arrhythmia encountered in clinical practice. One of its most devastating complications is the development of thromboembolism leading to fatal or disabling stroke. Oral anticoagulation (OAC, warfarin) is the standard treatment for stroke prevention in patients with AF with an increased stroke risk. However, there are several obstacles to long-term OAC therapy, including the risk of serious bleeding, several drug-drug interactions and the need for frequent blood testing. Although newer oral anticoagulants have been developed, these drugs also face issues of major bleeding and non-compliance. Therefore, alternative treatment options for stroke prevention in patients with AF with a high stroke risk are needed. Percutaneous left atrial appendage (LAA) occlusion is an evolving therapy, which should be taken into consideration in those patients with non-valvular AF with a high stroke risk and contraindications for OAC. This article aims to discuss the rationale for LAA closure, the available LAA occlusion devices and their clinical evidence until now. Moreover, we discuss the importance of proper patient selection, the role of various imaging techniques and the need for a more tailored postprocedural antithrombotic therapy.
O De Backer; S Arnous; N Ihlemann; N Vejlstrup; E Jørgensen; S Pehrson; T D W Krieger; P Meier; L Søndergaard; O W Franzen
Related Documents :
25442985 - Bridge to removal: a paradigm shift for left ventricular assist device therapy.
8546245 - Morbidity risk assessment in the surgically anemic patient.
25350985 - Ivabradine improves left ventricular function during chronic hypertension in conscious ...
25201905 - Impaired in vivo mitochondrial krebs cycle activity following myocardial infarction ass...
16271645 - Obesity and the risk of myocardial infarction in 27,000 participants from 52 countries:...
11275925 - Abciximab and early adjunctive percutaneous coronary intervention are associated with i...
Publication Detail:
Type:  Journal Article     Date:  2014-06-06
Journal Detail:
Title:  Open heart     Volume:  1     ISSN:  2053-3624     ISO Abbreviation:  Open Heart     Publication Date:  2014  
Date Detail:
Created Date:  2014-10-21     Completed Date:  2014-10-21     Revised Date:  2014-10-23    
Medline Journal Info:
Nlm Unique ID:  101631219     Medline TA:  Open Heart     Country:  England    
Other Details:
Languages:  eng     Pagination:  e000020     Citation Subset:  -    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Daylight savings time and myocardial infarction.
Next Document:  Major bleeding after percutaneous coronary intervention and risk of subsequent mortality: a systemat...